News & Insights
Specialization
- Mergers and acquisitions (M&A)
- Arbitration
- Litigation
- Capital Markets
- Compliance
- Private Equity
- Banking and Finance
- Competition and consumer law
- Labor law, management contracts
- White-collar crime
- Intellectual property law
- Bankruptcy and restructuring
- Life Sciences and Health Care
- Personal data
- Tax law
- Energy, public procurement, infrastructure projects
- Corporate law
- Financial litigation
- Risk & Support
- Real Estate
- German Desk
Person
- Beata Gessel-Kalinowska vel Kalisz, D.Sc.
- Marcin Macieszczak
- Leszek Koziorowski
- Aldona Pietrzak
- Christian Schmidt
- Piotr Schramm
- Małgorzata Badowska
- Krzysztof Marczuk
- Maciej Kożuchowski
- Bernadeta Kasztelan-Świetlik
- Michał Bochowicz
- Adam Kraszewski
- Karol Sokół
- Maciej Boryczko
- Dominika Ramírez-Wołkiewicz
- Joanna Kisielińska-Garncarek, PhD
- Krzysztof Jasiński
- Karolina Krzal-Kwiatkowska
- Magdalena Szeplik
- Michał Wieliński
- Katarzyna Bogusz-Grześkiewicz
- Maria Dudzińska
- Paweł Kwiatkowski
- Michał Osowski
- Aleksandra Szyszko-Kamińska
- Bartłomiej Woźniak PhD
- Anna Ziewalicz
- Monika Żulińska
- Inarda Bielińska
- Tomasz Drągowski
- Klaudia Krawiec-Guz
- Agnieszka Nowacka
- Hubert Wiśniewski
- Marta Grabiec
- Marcin Maciejak
- prof. dr hab. Marek Michalski
- Ludwik Żukowski
- Diana Strzałkowska-Grad
- Michał Brągiel
- Jakub Brzeski
- Emilia Chmielewska
- Tomasz Duda
- Maja Frontczak
- Aleksandra Głuszek
- Daria Golus
- Katarzyna Zarzycka
- Marcin Iwaniak
- Krzysztof Kaczor
- Dorota Kęsik
- Agnieszka Kolenda-Kuchcicka
- Weronika Korpalska
- Paweł Kosmal
- Sandra Kowalska
- Dominika Lara
- Natalia Leśna
- Karolina Olszewska
- Małgorzata Wiśniewska
- Maciej Michalak
- Martyna Milka
- Angelika Moskal
- Łukasz Naściuk
- Katarzyna Olszak
- Piotr Paprota
- Edyta Podgórska
- Jakub Rowicki
- Majka Rucińska
- Daniel Szemetyłło
- Barbara Tomczyk
- Katarzyna Wojciechowska
- Emilia Szkiela
- Erazm Dutkiewicz
- Maciej Kowalski
- Rafał Smolik
- Adrianna Andruszewska- Ożóg
- Wiktoria Bednarska-Busz
- Uladzimir Anhelski
- Walentyna Okuń
- Karolina Buchta
- Łukasz Ostas
- Karol Stępniak
- Michał Dunikowski
- Iwona Gielo-Benza
- Bernadeta Kołcz
- Maria Kozłowska
- Dawid Marciniak
- Natalia Niklińska, PhD
- Marcin Olszewski
- Piotr Zarkadas
- Karolina Sobóla
- Urszula Stachura
- Marcin Walczak
- Maciej Wąsowski
- Tomasz Wrondas
- Joanna Matusiak
- Jakub Nosal-Górski
- Vera Zalustkaya
- Anna Bednarczyk
- Grzegorz Gawliński
- Joanna Kurzyk
- Urszula Lipska
- Anna Michalak
- Katarzyna Olszewska
- Justyna Stąborowska
- Adriana Niecko
- Agnieszka Stępień
- Tomasz Szczepłek
- Dominika Wrzyszcz
- Agnieszka Antosiewicz
- Przemysław Banaszek
- Izabela Bukowińska
- Anna Bulik
- Samanta Dziubek
- Michał Godlewski
- Angela Hołownia
- Konrad Janowski
- Julia Kraśniewska
- Mikołaj Kurek
- Klaudia Mikuła
- Paulina Młodzianowska
- Małgorzata Olczak
- Anna Orłowska
- Paweł Panas
- Anna Paprocka
- Kinga Pecyna
- Karolina Popławska
- Barbara Potrawska
- Magdalena Rosińska
- Urszula Skibniewska
- Dorota Staniszewska-Kowalak
- Bartłomiej Świetlik
- Karolina Zalewska
- Mateusz Zglejszewski
Date
- Filter by dates
Active filters:
05.07.2023
We advised WSE-listed Bioceltix S.A. on a non-brokered public offering of the Company's shares
We advised WSE-listed Bioceltix S.A. on a non-brokered public offering of the Company's shares carried out under the accelerated book-building (ABB) p...
26.06.2023
We advised WSE-listed Pure Biologics S.A. on a PLN 12 million financing transaction
We advised WSE-listed Pure Biologics S.A. in a transaction to raise PLN 12 million in financing from a new investor, ACRX Investments Ltd. The transaction was executed ...
23.06.2023
We advised WSE-listed Genomtec S.A. on a non-brokered public offering
We advised WSE-listed Genomtec S.A. on a non-brokered public offering of the company's shares carried out under an accelerated bookbuilding procedure (ABB) and a related...
23.06.2023
We advised the WSE-listed Genomtec S.A. on its prospect-free IPO
We advised the WSE-listed Genomtec S.A. on a prospect-free public offering of the company's shares carried out under the accelerated bookbuilding procedure (ABB) and a r...
20.03.2023
GESSEL advises Urteste S.A. on a public placement of new issue shares and on transfer of its shares
GESSEL advises Urteste S.A. on a public placement of new issue shares and on transfer of its shares from the NewConnect alternative trading system to the main floor of t...
23.12.2022
GESSEL advises Pure Biologics S.A., a company listed on the Warsaw Stock Exchange
GESSEL supported Pure Biologics S.A. and its shareholders in preparation of a prospect-less public share offering via the accelerated book building process and execution...
09.12.2022
GESSEL advises on sale of a majority stake in Suwary S.A.
GESSEL advised the Management Board of Suwary S.A. and its former shareholders, Wentworth Tech sp. z o.o. and Savtec sp. z o.o., on a PLN 100 mln sale of 65% of Suwary S...
